Early Life
Alexey Evgenievich Repik was born on August 27, 1979, in Moscow, Russia. His father was a physicist, and his mother was an engineer. Repik showed an early interest in healthcare and pharmaceuticals. He graduated from the Higher School of Economics in 2003 with a degree in economics and enterprise management.
Rise to Success
Repik's career began in the healthcare sector in 1995. In 2001, he founded R-Pharm with a modest starting capital of $40,000. Under his leadership, R-Pharm rapidly expanded and secured significant government contracts, becoming a leading supplier of pharmaceuticals in Russia. In 2017, Mitsui & Co., Ltd. acquired a 10% share of R-Pharm for $200 million. Repik held the position of Chairman of the Board until 2022. R-Pharm was involved in producing a COVID-19 vaccine for AstraZeneca.
Key Business Strategies
Repik's business strategies included focusing on the development, research, and production of drugs. The company established manufacturing sites and research centers in multiple countries, including Russia, Japan, Germany, and the USA. Repik also emphasized international collaborations and invested heavily in infrastructure and research and development.
Philanthropy
Repik is involved in philanthropic activities, including donating to construct a shelter for dogs in Yaroslavl. He also established a scholarship program for students in the pharmaceutical industry.